"10.1371_journal.pone.0090284","plos one","2014-02-28T00:00:00Z","Andrea Chiricozzi; Kristine E Nograles; Leanne M Johnson-Huang; Judilyn Fuentes-Duculan; Irma Cardinale; Kathleen M Bonifacio; Nicholas Gulati; Hiroshi Mitsui; Emma Guttman-Yassky; Mayte Suárez-Fariñas; James G Krueger","Laboratory for Investigative Dermatology, The Rockefeller University, New York City, New York, United States of America; Center for Clinical and Translational Science, The Rockefeller University, New York City, New York, United States of America; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy; Department of Dermatology, Mount Sinai School of Medicine, New York City, New York, United States of America","¶ These authors are joint senior authors on this work.","The authors have read the journals policy and have the following conflict: the authors do not have any conflict of interest related to this work, with the exception of JGK who has been consultant to Eli Lilly (company developing ixekizumab) and Amgen (company developing etanercept) but this does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Andrea Chiricozzi","AC",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
